![](/img/cover-not-exists.png)
Phase I Clinical Trial Targeting CD20+ Non-Hodgkin'S Lymphoma (NHL) After Autologous Stem Cell Transplant With Anti-CD3 × Anti-CD20 Bispecific Antibody Armed T Cells
L.G. Lum, A. Thakur, V. Ratanatharathorn, Z. Al-Kadhimi, E. Paul, C. Skuba, P. Steel, L. Ayash, M. Abidi, J. Wedge, J.P. UbertiVolume:
17
Year:
2011
Language:
english
Pages:
1
DOI:
10.1016/j.bbmt.2010.12.027
File:
PDF, 92 KB
english, 2011